Heartpoint Global Hopes To Disrupt Congenital Pulmonary Hypertension Treatment With Minimally Invasive Device

Heartpoint Global Hopes To Disrupt Congenital Pulmonary Hypertension Treatment With Minimally Invasive Device

To correct high blood pressure of the pulmonary artery, which can arise from congenital defects of the heart, an artificial heart ucan cost upwards of $190,000. Heart disease accounted for about one in five deaths in 2020 in theUnited States.
Even minimally invasive pulmonary artery banding — a surgical technique that has been in use since Harry Truman was president — requires access to the chest cavity. A new treatment under development by HeartPoint Global seeks to provide a minimally invasive alternative to current treatments for pulmonary arterial hypertension associated with Congenital Heart Disease.A device delivered through the leg would cost only…

Continue Reading
VitalSight by OMRON Preview at CES 2023

VitalSight by OMRON Preview at CES 2023

VitalSight is a new tool for remote patient monitoring (RPM) from OMRON, a company that offers a wide range of health devices for blood pressure, respiratory problems, and more. Brandon Haag, OMRON's Director of Operations and Business Development, describes in this short video the operation of VitalSight and how it helps both the patient and their doctor treat hypertension. OMRON is working on adding more sources of data and medical conditions to this program.Learn more about VitalSight by OMRON: https://omronhealthcare.com/vitalsight/Find more great health IT content: https://www.healthcareittoday.com/…

Continue Reading
Cosmos, Epic's massive EHR analytics platform, helps reduce new mother readmissions

Cosmos, Epic’s massive EHR analytics platform, helps reduce new mother readmissions

Nearly 20% of postpartum patients in America develop high blood pressure; Epic Research just found in a new study that postpartum hypertension nearly triples the chances of rehospitalization.After looking at more than 1.2 million birth encounters and then grouping and comparing the highest blood pressure readings taken in the 24 hours after discharge, the study found:

Patients with blood pressure levels at or above 160/110 shortly before discharge are nearly three times more likely to be readmitted than patients with normal blood pressure readings.

More than 5% of postpartum patients with the highest blood pressure readings, equal to or greater than 160/110 mmHg,…

Continue Reading